{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:07:08Z","timestamp":1791025628271,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Austrian Science Fund","award":["DK-MCD W1226"],"award-info":[{"award-number":["DK-MCD W1226"]}]},{"name":"Austrian Science Fund","award":["SFB LIPOTOX F30"],"award-info":[{"award-number":["SFB LIPOTOX F30"]}]},{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bbalip.2013.04.012","type":"journal-article","created":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T09:45:47Z","timestamp":1366969547000},"page":"1555-1565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The PPAR\u03b1 agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism"],"prefix":"10.1016","volume":"1831","author":[{"given":"Jianfeng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Al Zoughbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Claudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Sexl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Vesely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Birner-Gruenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Kratky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Hoefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2013.04.012_bb0005","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0010","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2011.06.029","article-title":"Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies","volume":"47","author":"Larsson","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0015","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1158\/1055-9965.779.13.5","article-title":"Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma","volume":"13","author":"Skibola","year":"2004","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0020","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/leu.2008.57","article-title":"HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia","volume":"22","author":"Whelan","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12032-008-9084-9","article-title":"Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly","volume":"26","author":"Taslipinar","year":"2009","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.numecd.2008.06.002","article-title":"Serum lipoproteins and cancer","volume":"19","author":"Muntoni","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s005990070013","article-title":"Serum lipoprotein profile in patients with cancer, a comparison with non-cancer subjects","volume":"30","author":"Fiorenza","year":"2000","journal-title":"Int. J. Clin. Lab. Res."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3835(94)90008-6","article-title":"Alterations of serum lipids and lipoproteins in breast cancer","volume":"82","author":"Kokoglu","year":"1994","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2478\/s11658-008-0014-9","article-title":"Lipid changes occurring in the course of hematological cancers","volume":"13","author":"Kuliszkiewicz-Janus","year":"2008","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0050","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","article-title":"Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta","volume":"94","author":"Forman","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s000110050622","article-title":"Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation","volume":"49","author":"Chinetti","year":"2000","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3214","article-title":"The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention","volume":"12","author":"Peters","year":"2012","journal-title":"Nat. Rev."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/emmm.201000062","article-title":"Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia","volume":"2","author":"Hoelbl","year":"1992","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-2275(20)41889-9","article-title":"Quantitative measurement of lipoprotein surface charge by agarose gel electrophoresis","volume":"33","author":"Sparks","year":"1992","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0080","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1038\/cddis.2012.91","article-title":"Skeletal muscle damage and impaired regeneration due to LPL-mediated lipotoxicity","volume":"3","author":"Tamilarasan","year":"2012","journal-title":"Cell death Dis."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/nano.2006.1.2.129","article-title":"Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review","volume":"1","author":"Tziomalos","year":"2006","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0100","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1073\/pnas.0711281105","article-title":"PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition","volume":"105","author":"Panigrahy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0105","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/leu.2010.117","article-title":"Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha\/NF-kappaB signaling axis","volume":"24","author":"Zak","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0110","doi-asserted-by":"crossref","first-page":"e002","DOI":"10.1621\/nrs.08002","article-title":"PPARalpha: energy combustion, hypolipidemia, inflammation and cancer","volume":"8","author":"Pyper","year":"2010","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0115","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2012-04-424630","article-title":"Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0120","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1182\/blood-2012-05-428466","article-title":"Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab\/R-CHOP","volume":"120","author":"Gupta","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0125","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cyto.2012.08.028","article-title":"Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study","volume":"60","author":"Charbonneau","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3858\/emm.2009.41.6.045","article-title":"Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice","volume":"41","author":"Jeong","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2006-927368","article-title":"Lipid metabolism in the liver","volume":"45","author":"Canbay","year":"2007","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.nutr.21.1.193","article-title":"Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system","volume":"21","author":"Reddy","year":"2001","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0150","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1073\/pnas.88.24.11335","article-title":"Blast crisis in a murine model of chronic myelogenous leukemia","volume":"88","author":"Daley","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0155","doi-asserted-by":"crossref","first-page":"e33738","DOI":"10.1371\/journal.pone.0033738","article-title":"Blockade of fatty acid synthase triggers significant apoptosis in mantle cell lymphoma","volume":"7","author":"Gelebart","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0160","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1073\/pnas.1205995109","article-title":"Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma","volume":"109","author":"Bhatt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.leu.2405058","article-title":"Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells","volume":"22","author":"Pallasch","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0170","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.ejcn.1600843","article-title":"Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight","volume":"53","author":"Korber","year":"1999","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0180","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00726-011-0898-y","article-title":"l-carnitine induces recovery of liver lipid metabolism in cancer cachexia","volume":"42","author":"Silverio","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbalip.2013.04.012_bb0185","doi-asserted-by":"crossref","first-page":"13B","DOI":"10.1016\/S0002-9149(98)00032-0","article-title":"Atherogenicity of triglyceride-rich lipoproteins","volume":"81","author":"Krauss","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","article-title":"Role of cholesterol in the development and progression of breast cancer","volume":"178","author":"Llaverias","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0195","first-page":"1055","article-title":"Potential antitumor effects of statins (Review)","volume":"23","author":"Jakobisiak","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0200","doi-asserted-by":"crossref","first-page":"28210","DOI":"10.1074\/jbc.272.45.28210","article-title":"Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators","volume":"272","author":"Martin","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0205","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1002\/j.1460-2075.1996.tb00918.x","article-title":"PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene","volume":"15","author":"Schoonjans","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0210","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1074\/jbc.272.43.27307","article-title":"Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice","volume":"272","author":"Peters","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0215","first-page":"E421","article-title":"PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1","volume":"292","author":"Qu","year":"2007","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0220","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00041433-200106000-00009","article-title":"Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism","volume":"12","author":"Shachter","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2013.04.012_bb0225","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1371\/journal.pone.0000260","article-title":"PPARalpha deficiency in inflammatory cells suppresses tumor growth","volume":"2","author":"Kaipainen","year":"2007","journal-title":"PLoS One"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198113000978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198113000978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T08:17:40Z","timestamp":1688199460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198113000978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1388198113000978"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2013.04.012","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The PPAR\u03b1 agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2013.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}